Select Page

53BP1 Polyclonal Antibody – E-AB-30372

  • Clonality : Rabbit Polyclonal
  • Applications : WB | IHC | IF | ELISA
  • Reactivity : Human | Mouse | Rat

169.00$599.00$ CAD

0 in stock (expect 7-14 days for delivery)

Clear

Cashback Reward : Earn up to 59$!


53BP1 Polyclonal Antibody


Background information : TP53BP1 (tumor protein p53 binding protein 1) is a protein-coding gene. Go annotations related to this gene include methylated histone residue binding and p53 binding.Plays a key role in the response to DNA damage. May have a role in checkpoint signaling during mitosis.Enhances TP53-mediated transcriptional activation.


Research area(s) :


Alternate names: TP53BP1, Tumor suppressor p53-binding protein 1, 53BP1, p53-binding protein 1, p53BP1


Validated applications : WB | IHC | IF | ELISA


Suggested dilutions : WB 1:500-1:2000, IHC 1:50-1:200, IF 1:50-1:100, ELISA 1:5000-1:20000


Calculated MW : 214 kDa


Observed MW (if applicable)  : 213 kDa


Available sizes : 20 ul, 60 ul, 120 ul, 200 ul


Conjugation : none


Clonality : Polyclonal


Isotype : IgG


Clone number :


Reactivity : Human | Mouse | Rat


Immunogen : Synthesized peptide derived from human 53BP1 around the non-phosphorylation site of S6.


Purification method : Affinity purification


Supplied in : PBS with 0.02% sodium azide,50% glycerol and 0.5%BSA


Concentration : 1 mg/mL


Storage : Store at-20 °C. Avoid freeze / thaw cycles.


Swissprot ID : Q12888


Gene ID / Accession : 7158 /


Other informations :

Link to Elabscience product page


Previous Catalog Number: ENT0024


Manual & Datasheet


Additional information

Format

20 ul, 60 ul, 120 ul, 200 ul

Product Name

53BP1 Polyclonal Antibody

Clonality

Polyclonal

Validated Applications

WB, IHC, IF, ELISA

Reactivity

Human, Mouse, Rat

Supplier

Ask a question about 53BP1 Polyclonal Antibody – E-AB-30372

Reviews for 53BP1 Polyclonal Antibody – E-AB-30372

Reviews

    Be the first to review “53BP1 Polyclonal Antibody – E-AB-30372”

    Your email address will not be published. Required fields are marked *